Michael Gladstone

Insider Reports History

Entity
Individual
Location
395 Oyster Point Blvd, Suite 217, South San Francisco, California
Signature
/s/ Christopher Murphy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Gladstone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Day One Biopharmaceuticals, Inc. Director Director Stock Option (Right to buy Common Stock) 37.5 K Jun 22, 2023 Direct
Day One Biopharmaceuticals, Inc. Director Stock Option (right to buy Common Stock) 32.3 K May 23, 2024 Direct
Third Harmonic Bio, Inc. Director, 10%+ Owner Director Stock Option (right to buy) 20 K Jun 6, 2024 Direct

Insider Reports Filed by Michael Gladstone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
THRD Third Harmonic Bio, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director, 10%+ Owner
DAWN Day One Biopharmaceuticals, Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
DAWN Day One Biopharmaceuticals, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
THRD Third Harmonic Bio, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
THRD Third Harmonic Bio, Inc. Oct 26, 2022 1 $0 4 Oct 27, 2022 Director
THRD Third Harmonic Bio, Inc. Sep 14, 2022 0 $0 3 Sep 14, 2022 Director
DAWN Day One Biopharmaceuticals, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
DAWN Day One Biopharmaceuticals, Inc. Jun 17, 2022 1 $11.5 M 4 Jun 22, 2022 Director
DAWN Day One Biopharmaceuticals, Inc. May 26, 2021 0 $0 3 May 26, 2021 Director